Global News

[ad_1] Travelers from China will need to test negative for COVID-19 before boarding flights to the U.S. starting next week, the Centers for Disease Control and Prevention announced Wednesday. The testing requirement will apply to travelers from mainland China, Hong Kong and Macau, and covers all passengers regardless of their nationality or vaccination status, the CDC said.  Americans should also "reconsider travel to China, Hong Kong, and Macau," the CDC now urges. In a  travel alert  published Wednesday, the agency cited "reports that the healthcare system is overwhelmed," along with the risk of new variants. Beyond masking while traveling in places like airports or planes, the CDC also recommends that Americans visiting China wear masks while indoors in public. The moves come amid a record wave of infections in China since it relaxed its "zero COVID" policy in early December. The Chinese government has

[ad_1] A vial labelled "Novavax V COVID-19 Vaccine" is seen in this illustration taken January 16, 2022.  Dado Ruvic | Reuters Novavax 's updated Covid vaccine won the backing of U.S. regulators on Tuesday, putting the shot on track to roll out weeks after new jabs from Pfizer and Moderna reached Americans. The Food and Drug Administration authorized Novavax's single-strain vaccine, which targets omicron subvariant XBB.1.5 , for emergency use in people ages 12 and up. The Centers for Disease Control and Prevention is now including Novavax's shot in the same recommendation it issued last month for updated vaccines from Pfizer and Moderna. That recommendation says all Americans ages six months and older can receive an updated Covid jab. Novavax said in a statement that doses of the shot will likely be available within the next few days. "Novavax's authorization today means people will now have the choice of a protein-based non-MRNA option to help

[ad_1] Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Images U.S. Food and Drug Administration staff on Tuesday said Pfizer's vaccine that protects infants from respiratory syncytial virus has "generally favorable" safety data. The FDA staff made the conclusion in briefing documents ahead of a meeting on Thursday when a panel of external advisors to the agency will discuss whether to recommend full approval of the RSV shot . The advisors will vote on whether Pfizer's late-stage clinical trial data on the vaccine supports its safety and efficacy. The FDA typically follows the advice of its advisory committees, but is not required to do so. The agency is slated to make a decision on whether to clear the shot in August before RSV season in the fall. If approved, Pfizer's jab would become the world's first vaccine that protects infants against RSV.  RSV usually causes mild, cold-like symptoms. But infants and older ad

[ad_1] Twenty-year-old Alex Morrin says an unexpected danger of vaping is it is easy to hide. "You can do it in the same room as them," Morrin told CBS News of vaping around his parents. "It vaporizes," Winna Morrin, Alex's mother, added. "So you don't see any smoke." A new U.S. Centers for Disease Control and Prevention report released Friday — based on 2021 data from a National Health Interview Survey — found that 11% of 18- to 24-year-olds define themselves as current e-cigarette users, more than any other age group of adults. The report also found that White non-Hispanic Americans between 18 and 24 vape more than Latino, Asian or Black youth in the same age group. Overall, the survey found that 4.5% of adults ages 18 and over vape. The survey defined current e-cigarette use as respondents who say they vape "every day" or "some days." It's not just young adults who vap

[ad_1] A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images The Biden administration on Thursday announced a program to provide free Covid vaccines to uninsured Americans through December 2024 after the federal government's supply of shots runs out this fall. Those free shots, which the government is purchasing at a discount, will be available to the uninsured at pharmacies and 64 state and local health departments. The Health and Human Services Department also is hoping that vaccine makers will donate shots to pharmacies as part of the program. There are between 25 to 30 million uninsured adults in the United States and other Americans whose insurance will not cover free Covid products this fall, according to the federal Centers for Disease Control and Prevention. Currently, the government has an